Report copyright - oncoletter 2017/0… · Durvalumab + Tremelimumab vs Durvalumab vs Tremelimumab in I-ICC Arm + (n=36; 12 subjoctstviral status typo) ... ASCO 2016. Abstract 4012. 2017 Gastrointestinal
Please pass captcha verification before submit form